ArticleInternational journal of molecular sciences2019
Curcumin Mitigates Immune-Induced Epithelial Barrier Dysfunction by
Open access · goldAbstract read
In one paragraph
Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 44 citations in OpenAlex.
- Evaluation of color stability and material surface stability of different types of clear aligners under curcumin staining in vitro.BMC oral health · 2025Article
- Curcuma Longa (turmeric): from traditional applications to modern plant medicine research hotspots.Chinese medicine · 2025Review
- Article
- Oral curcumin ameliorates acute murine campylobacteriosis.Frontiers in immunology · 2024Article
- Phytogenics in Ginger,Animals : an open access journal from MDPI · 2023Review
- Therapeutic Effects of Oral Application of Menthol and Extracts from Tormentil (Pharmaceutics · 2023Article
- Intestinal Barrier in Post-Biomolecules · 2023Article
- Molecular Targets inBiomolecules · 2023Review
- Evolution and Role of Proteases inBiomolecules · 2023Review
- Myrrh protects against IL-13-induced epithelial barrier breakdown in HT-29/B6 cells.Frontiers in pharmacology · 2023Article
- Review
- Tight junction disruption through activation of the PI3K/AKT pathways in the skin contributes to blister fluid formation after severe tibial plateau fracture.Frontiers in bioengineering and biotechnology · 2022Article
- Vitamin D Reverses Disruption of Gut Epithelial Barrier Function Caused byInternational journal of molecular sciences · 2021Article
- InVitro Models of Intestine Innate Immunity.Trends in biotechnology · 2021Review
- Immune-Mediated Aggravation of theInternational journal of molecular sciences · 2021Article
- Resveratrol PreventsFrontiers in pharmacology · 2021Article
- Campylobacter sp.: Pathogenicity factors and prevention methods-new molecular targets for innovative antivirulence drugs?Applied microbiology and biotechnology · 2020Review
- Toll-Like Receptor-4 Is Involved in Mediating Intestinal and Extra-Intestinal Inflammation inMicroorganisms · 2020Article
- Resveratrol Alleviates AcuteMicroorganisms · 2020Article
- Special Issue on "The Tight Junction and Its Proteins: More than Just a Barrier".International journal of molecular sciences · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 4 institutions in 1 country.
Fábia Daniela Lobo de SáInstitute of Clinical Physiology/Nutritional Medicine, Medical Department, Division of Gastroenterology, Infectiology, Rheumatology, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany. fabia.lobo-da-fonseca@charite.de.ORCID 0000-0002-1968-3468
Eduard ButkevychInstitute of Clinical Physiology/Nutritional Medicine, Medical Department, Division of Gastroenterology, Infectiology, Rheumatology, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany. eduard.butkevych@charite.de.
Praveen Kumar NattramilarasuInstitute of Clinical Physiology/Nutritional Medicine, Medical Department, Division of Gastroenterology, Infectiology, Rheumatology, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany. praveen-kumar.nattramilarasu@charite.de.
Anja FrommInstitute of Clinical Physiology/Nutritional Medicine, Medical Department, Division of Gastroenterology, Infectiology, Rheumatology, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany. anja.fromm@charite.de.ORCID 0000-0003-4091-9612
Soraya MousaviInstitute of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, 14195 Berlin, Germany. soraya.mousavi@charite.de.
Verena MoosMedical Department, Division of Gastroenterology, Infectiology and Rheumatology, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany. verena.moos@charite.de.ORCID 0000-0002-9558-7291
Julia C GolzGerman Federal Institute for Risk Assessment (BfR), Department of Biological Safety, National Reference Laboratory for Campylobacter, 12277 Berlin, Germany. julia.golz@bfr.bund.de.
Kerstin StinglGerman Federal Institute for Risk Assessment (BfR), Department of Biological Safety, National Reference Laboratory for Campylobacter, 12277 Berlin, Germany. kerstin.stingl@bfr.bund.de.
Sophie KittlerUniversity of Veterinary Medicine Hannover, Research Center for Emerging Infections and Zoonoses, 30559 Hannover, Germany. sophie.kittler@tiho-hannover.de.
Diana SeinigeUniversity of Veterinary Medicine Hannover, Research Center for Emerging Infections and Zoonoses, 30559 Hannover, Germany. diana.seinige@tiho-hannover.de.
Corinna KehrenbergInstitute for Veterinary Food Science, Justus-Liebig-University, 35392 Giessen, Germany. corinna.kehrenberg@vetmed.uni-giessen.de.
Markus M HeimesaatInstitute of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, 14195 Berlin, Germany. markus.heimesaat@charite.de.
Stefan BereswillInstitute of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, 14195 Berlin, Germany. stefan.bereswill@charite.de.
Jörg-Dieter SchulzkeInstitute of Clinical Physiology/Nutritional Medicine, Medical Department, Division of Gastroenterology, Infectiology, Rheumatology, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany. joerg.schulzke@charite.de.ORCID 0000-0001-9947-5521
Roland BückerInstitute of Clinical Physiology/Nutritional Medicine, Medical Department, Division of Gastroenterology, Infectiology, Rheumatology, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany. roland-felix.buecker@charite.de.ORCID 0000-0002-1345-4146
Charité - Universitätsmedizin Berlin · DEFederal Institute for Risk Assessment · DEUniversity of Veterinary Medicine Hannover, Foundation · DEJustus-Liebig-Universität Gießen · DE
Funding
Bundesministerium für Bildung und Forschung IP8/01KI1725D
Abstract
PubMed holds no abstract for this paper.
Indexed as
AnimalsAnti-Inflammatory Agents, Non-SteroidalApoptosisCampylobacter InfectionsCampylobacter jejuniCell LineCoculture TechniquesCurcuminCytokinesEpithelial CellsHumansInterleukin-10Intestinal MucosaMiceMice, KnockoutMucous MembraneAnti-Inflammatory Agents, Non-SteroidalCurcuminCytokinesInterleukin-10Tight Junction ProteinsapoptosisCampylobacter jejuniclaudinco-culturecurcumincytokinesmouse colonNFκBtight junctionTNF
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.